Home NDC 72495-601-28 FEMLYV
Product NDC 72495-601
Requested package NDC 72495-601-28
11-digit product format 724950601
Labeler code 72495
Product ID 72495-601_5bfa2209-e9bb-4d9b-97cb-2f8cd0058178
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Norethindrone Acetate/Ethinyl Estradiol
Dosage form KIT
Labeler Millicent US, Inc.
Application NDA218718
Marketing category NDA
Marketing start 2024-11-01
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N218718-001 FEMLYV ETHINYL ESTRADIOL; NORETHINDRONE ACETATE 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22
Orange Book patents# Current patent rows page 1 of 1 · 1 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N218718-001 12178824 2041-06-24 Drug product 2025-01-10
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N218718-001 NP 2027-07-22
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 84e616aacf4f…2026-08-18 06:07:40 2026-07 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 79d66fd596c7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218718-001 FEMLYV 0.02MG;1MG TABLET, ORALLY DISINTEGRATING / ORAL RLD, RS 2024-07-22 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N218718-001 12178824 2041-06-24 Drug product 2025-01-10 84e616aacf4f…2026-08-18 06:07:40 2026-07 N218718-001 12178824 2041-06-24 Drug product 2025-01-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N218718-001 12178824 2041-06-24 Drug product 2025-01-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N218718-001 12178824 2041-06-24 Drug product 2025-01-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N218718-001 12178824 2041-06-24 Drug product 2025-01-10 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N218718-001 12178824 2041-06-24 Drug product 2025-01-10 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N218718-001 12178824 2041-06-24 Drug product 2025-01-10 b8a1b40f171c…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N218718-001 12178824 2041-06-24 Drug product 2025-01-10 a50c72e98297…
Observed Orange Book exclusivity history# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base FEMLYV
Listing expiration 2026-12-31 Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 4 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 2696883 Internal RxNorm lookup 2696886 Internal RxNorm lookup 2696887 Internal RxNorm lookup 2696888 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72495-601 FEMLYV (NORETHINDRONE ACETATE/ETHINYL ESTRADIOL) KIT [MILLICENT US, INC.] 2 Current NDC, 4 package rows 20241102_a3c99fc1-9b05-4f0a-ad00-5e3e206302c9.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 72495-601-28 72495060128 1 POUCH in 1 CARTON (72495-601-28) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK 1 pouch 2024-11-01 No No Current